U.S. Probe of Drug Maker Falters As Company Resists

Print More

To combat an escalating opioid epidemic, the Drug Enforcement Administration focused in 2011 on Mallinckrodt Pharmaceuticals, one of the nation’s largest manufacturers of the addictive painkiller oxycodone, the Washington Post reports. It was the first time DEA targeted a manufacturer of opioids for alleged violations of laws to prevent diversion of legal narcotics to the black market . . .

Want to read more? Please subscribe to The Crime Report!